VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2017 | Complex karyotypes and their prognostic value in CLL

Paolo Ghia, MD, PhD, from the San Raffaele Scientific Institute, Milano, Italy discusses the prognostic value of complex karyotypes in chronic lymphocytic leukemia (CLL) and details the results from his team’s analysis on 4,000 samples from CLL patients to evaluate this prognostic value and what these karyotypes may predict. He also notes that these results cannot currently be used in clinical trials, although they will definitely be relevant in the future. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter